10 Sep 2024 | 03:51 pm | 1 min. read
Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.
Jim Cormack (Global Head of Risk Advisory Services), Pinsent Masons, said: "These new appointments reflect the strength and diversity of our global IP and life sciences practice. Judith, Tom and Charlotte are outstanding lawyers with proven track records of delivering excellent service to our clients across a range of sectors and jurisdictions. They have the vision, skills and experience to lead our teams and drive our strategy in these key areas of our business."
"We would also like to thank Clare for her contribution to the firm. She has played a key role in the growth of our IP and Life Sciences practice and we wish her all the best for the future."
Biographies:
Judith Krens joined Pinsent Masons in 2022 as a partner in the Amsterdam office, where she heads the IP practice. She is a leading patent litigator with extensive experience in complex cross-border patent disputes and LS regulatory disputes. She is also a UPC representative and litigates in the UPC. She advises clients in various sectors, including life sciences, technology, and consumer goods.
Tom Nener joined Pinsent Masons in 2019 and became a partner in the Birmingham office in 2022, where he co-led our international Brand Protection and Creative Rights team. He is a recognised expert in IP litigation with a focus on brand protection, creative rights and trade secrets. He acts for clients in a range of industries, such as technology, sports, retail and consumer, manufacturing and automotive.
Charlotte Weekes joined Pinsent Masons in 2010 and became a partner in the London office in 2015, where she is a member of the IP team and previously led the Generics & Biosimilars Focus Group. She is a specialist in life sciences having advised clients in the sector for more than 20 years. Charlotte’s background is in life sciences patent and Supplementary Protection Certificate litigation, regularly co-ordinating pan-EU strategies to support clients bringing products to market or seeking to maintain their market position.
Key Contacts
Multinational law firm Pinsent Masons has successfully represented Mr. Ferri-Ricchi, a foreign exchange trader, in what is believed to be the highest value bonus claim ever brought before the Dubai International Financial Centre Court of First Instance.
Multinational law firm Pinsent Masons has appointed pensions partner, Ian Mylrea, to join the firm’s financial services sector in Manchester
Multinational law firm Pinsent Masons will continue its strong growth in Australia at a new Sydney address after signing a lease to move into one of the city’s most iconic addresses.
Multinational law firm Pinsent Masons has advised Netherlands-based MedTech startup OASYS NOW on its journey to receive its first equity investment.
Multinational law firm Pinsent Masons advised Clarios on its investment in Altris as part of the Series B1 financing round.
Multinational law firm Pinsent Masons has unveiled its 2023/24 year end results, announcing a 7.2% revenue increase to £649.6m as it continues to develop its cross border, sector-led capabilities prioritising investment into its people, client service and communities.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]